Targeting Angiogenesis in Childhood Sarcomas

by Hemant K. Bid, Peter J. Houghton
Published 2011-01-01

Developing New Agents for Treatment of Childhood Cancer: Challenges and Opportunities for Preclinical Testing

by Samson Ghilu, Raushan T. Kurmasheva, Peter J. Houghton
Published 2021-04-01

Preclinical Childhood Tumor Models: Drug Efficacy Biomarker Identification and Validation

by Brian eGeier, Dias eKurmashev, Raushan T Kurmasheva, Peter J Houghton
Published 2015-08-01

Correction: Anti-Tumor Activity of a Novel HS-Mimetic-Vascular Endothelial Growth Factor Binding Small Molecule.

by Kazuyuki Sugahara, Kuntebommanahalli N. Thimmaiah, Hemant K. Bid, Peter J. Houghton, Kanchugarakoppal S. Rangappa
Published 2012-01-01

Correction: Anti-Tumor Activity of a Novel HS-Mimetic-Vascular Endothelial Growth Factor Binding Small Molecule

by Basappa, Kazuyuki Sugahara, Kuntebommanahalli N. Thimmaiah, Hemant K. Bid, Peter J. Houghton, Kanchugarakoppal S. Rangappa
Published 2012-01-01

Anti-tumor activity of a novel HS-mimetic-vascular endothelial growth factor binding small molecule.

by Basappa, Kazuyuki Sugahara, Kuntebommanahalli N Thimmaiah, Hemant K Bid, Peter J Houghton, Kanchugarakoppal S Rangappa
Published 2012-01-01

Regulation of CHK1 by mTOR contributes to the evasion of DNA damage barrier of cancer cells

by Xinhui Zhou, Weijin Liu, Xing Hu, Adrienne Dorrance, Ramiro Garzon, Peter J. Houghton, Changxian Shen
Published 2017-05-01

Anti-angiogenic activity of a small molecule STAT3 inhibitor LLL12.

by Hemant K Bid, Duane Oswald, Chenglong Li, Cheryl A London, Jiayuh Lin, Peter J Houghton
Published 2012-01-01

Hypoxic Proliferation of Osteosarcoma Cells Depends on Arginase II

by Bhuvana A. Setty, Yi Jin, Peter J. Houghton, Nicholas D. Yeager, Thomas G. Gross, Leif D. Nelin
Published 2016-08-01

GDF6-CD99 Signaling Regulates Src and Ewing Sarcoma Growth

by Fuchun Zhou, David J. Elzi, Panneerselvam Jayabal, Xiuye Ma, Yu-Chiao Chiu, Yidong Chen, Barron Blackman, Susan T. Weintraub, Peter J. Houghton, Yuzuru Shiio
Published 2020-11-01

Dihydroartemisinin Inhibits mTORC1 Signaling by Activating the AMPK Pathway in Rhabdomyosarcoma Tumor Cells

by Jun Luo, Yoshinobu Odaka, Zhu Huang, Bing Cheng, Wang Liu, Lin Li, Chaowei Shang, Chao Zhang, Yang Wu, Yan Luo, Shengyong Yang, Peter J. Houghton, Xiaofeng Guo, Shile Huang
Published 2021-06-01

Classical NF-κB Metabolically Reprograms Sarcoma Cells Through Regulation of Hexokinase 2

by Priya Londhe, Priya Londhe, Peter Y. Yu, Peter Y. Yu, Yuichi Ijiri, Yuichi Ijiri, Katherine J. Ladner, Katherine J. Ladner, Joelle M. Fenger, Cheryl London, Cheryl London, Peter J. Houghton, Denis C. Guttridge, Denis C. Guttridge
Published 2018-04-01

Surfaceome Profiling of Rhabdomyosarcoma Reveals B7-H3 as a Mediator of Immune Evasion

by Roxane R. Lavoie, Patricio C. Gargollo, Mohamed E. Ahmed, Yohan Kim, Emily Baer, Doris A. Phelps, Cristine M. Charlesworth, Benjamin J. Madden, Liguo Wang, Peter J. Houghton, John Cheville, Haidong Dong, Candace F. Granberg, Fabrice Lucien
Published 2021-09-01

Prioritization of Novel Agents for Patients with Rhabdomyosarcoma: A Report from the Children’s Oncology Group (COG) New Agents for Rhabdomyosarcoma Task Force

by Holly L. Pacenta, Wendy Allen-Rhoades, David Langenau, Peter J. Houghton, Charles Keller, Christine M. Heske, Michael D. Deel, Corinne M. Linardic, Jack F. Shern, Elizabeth Stewart, Brian Turpin, Douglas J. Harrison, Javed Khan, Leo Mascarenhas, Stephen X. Skapek, William H. Meyer, Douglas S. Hawkins, Eleanor Y. Chen, James F. Amatruda, Pooja Hingorani, Theodore W. Laetsch
Published 2021-04-01

Forty-five patient-derived xenografts capture the clinical and biological heterogeneity of Wilms tumor

by Andrew J. Murphy, Xiang Chen, Emilia M. Pinto, Justin S. Williams, Michael R. Clay, Stanley B. Pounds, Xueyuan Cao, Lei Shi, Tong Lin, Geoffrey Neale, Christopher L. Morton, Mary A. Woolard, Heather L. Mulder, Hyea Jin Gil, Jerold E. Rehg, Catherine A. Billups, Matthew L. Harlow, Jeffrey S. Dome, Peter J. Houghton, John Easton, Jinghui Zhang, Rani E. George, Gerard P. Zambetti, Andrew M. Davidoff
Published 2019-12-01

Genomic Profiling of Childhood Tumor Patient-Derived Xenograft Models to Enable Rational Clinical Trial Design

by Jo Lynne Rokita, Komal S. Rathi, Maria F. Cardenas, Kristen A. Upton, Joy Jayaseelan, Katherine L. Cross, Jacob Pfeil, Laura E. Egolf, Gregory P. Way, Alvin Farrel, Nathan M. Kendsersky, Khushbu Patel, Krutika S. Gaonkar, Apexa Modi, Esther R. Berko, Gonzalo Lopez, Zalman Vaksman, Chelsea Mayoh, Jonas Nance, Kristyn McCoy, Michelle Haber, Kathryn Evans, Hannah McCalmont, Katerina Bendak, Julia W. Böhm, Glenn M. Marshall, Vanessa Tyrrell, Karthik Kalletla, Frank K. Braun, Lin Qi, Yunchen Du, Huiyuan Zhang, Holly B. Lindsay, Sibo Zhao, Jack Shu, Patricia Baxter, Christopher Morton, Dias Kurmashev, Siyuan Zheng, Yidong Chen, Jay Bowen, Anthony C. Bryan, Kristen M. Leraas, Sara E. Coppens, HarshaVardhan Doddapaneni, Zeineen Momin, Wendong Zhang, Gregory I. Sacks, Lori S. Hart, Kateryna Krytska, Yael P. Mosse, Gregory J. Gatto, Yolanda Sanchez, Casey S. Greene, Sharon J. Diskin, Olena Morozova Vaske, David Haussler, Julie M. Gastier-Foster, E. Anders Kolb, Richard Gorlick, Xiao-Nan Li, C. Patrick Reynolds, Raushan T. Kurmasheva, Peter J. Houghton, Malcolm A. Smith, Richard B. Lock, Pichai Raman, David A. Wheeler, John M. Maris
Published 2019-11-01